Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites
- PMID: 208985
- DOI: 10.1002/ijc.2910210416
Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites
Abstract
Circulating immune complexes were measured in sequential monitoring studies in rats bearing chemically induced tumours at different body sites. The assay employed were based upon radioimmunoprecipitation of serum factors with 125I-C1q or with an indirect test whereby the inhibition of binding of 125I-C1q to IgG aggregates by tumour-bearer sera was measured. 125I-C1q-binding immune complexes were detected at the initial phase of tumour growth and the level of this activity returned to the normal range after tumour excision. With tumour growing at subcutaneous sites or in th peritoneal cavity, serum-borne C1q-binding material, after reaching a maximum level, decreased despite tumour progression and eventually fell into sub-normal ranges at terminal stages of growth. In contrast, following intravenous tumour cell injection, immune-complex levels increased until terminal stages of disease. The present findings indicate that the measurement of C1q-binding serum factors represents a useful method for monitoring the growth and burden of experimental animal tumours.
Similar articles
-
Circulating immune complexes in rats bearing chemically induced tumours. II. Characterization of sera from different stages of tumour growth.Int J Cancer. 1978 Nov 15;22(5):576-82. doi: 10.1002/ijc.2910220512. Int J Cancer. 1978. PMID: 214404
-
Cell-mediated cytotoxicity to chemically-induced rat tumours.Int J Cancer. 1975 Oct 15;16(4):593-606. doi: 10.1002/ijc.2910160409. Int J Cancer. 1975. PMID: 170224
-
Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts.Int J Cancer. 1976 Jan 15;17(1):129-37. doi: 10.1002/ijc.2910170117. Int J Cancer. 1976. PMID: 175021
-
Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.Proc R Soc Med. 1973 May;66(5):466-8. doi: 10.1177/003591577306600523. Proc R Soc Med. 1973. PMID: 4351926 Free PMC article. Review. No abstract available.
-
[Circulating IgG-containing immune complexes in malignant growth].Eksp Onkol. 1986;8(3):10-7. Eksp Onkol. 1986. PMID: 2424714 Review. Russian.
Cited by
-
Immunologic enhancement of experimental metastasis in the rat.Cancer Immunol Immunother. 1984;17(1):42-50. doi: 10.1007/BF00205496. Cancer Immunol Immunother. 1984. PMID: 6563943 Free PMC article.
-
Tumour markers with unknown functions in gynaecological neoplasia.Arch Gynecol. 1980;229(4):325-31. doi: 10.1007/BF02108583. Arch Gynecol. 1980. PMID: 7416810
-
"Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.Front Oncol. 2021 Feb 24;10:627701. doi: 10.3389/fonc.2020.627701. eCollection 2020. Front Oncol. 2021. PMID: 33718121 Free PMC article. Review.
-
Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumor growth.Am J Pathol. 1980 Aug;100(2):403-10. Am J Pathol. 1980. PMID: 7406017 Free PMC article.
-
Immunomodulatory effect of cyclophosphamide on host humoral immunity in Dunning's R-3327 adenocarcinoma of the prostate.Urol Res. 1991;19(1):15-8. doi: 10.1007/BF00294015. Urol Res. 1991. PMID: 2028560
MeSH terms
Substances
LinkOut - more resources
Full Text Sources